Concepts (246)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Caregivers | 10 | 2023 | 2241 | 1.800 |
Why?
|
| Quality of Life | 27 | 2024 | 13347 | 1.280 |
Why?
|
| Cost-Benefit Analysis | 15 | 2023 | 5491 | 1.260 |
Why?
|
| Economics, Medical | 3 | 2023 | 112 | 1.200 |
Why?
|
| Family | 7 | 2021 | 3193 | 1.150 |
Why?
|
| Health Status | 18 | 2024 | 4075 | 0.910 |
Why?
|
| Alcoholism | 2 | 2021 | 1972 | 0.680 |
Why?
|
| Choice Behavior | 2 | 2016 | 825 | 0.660 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2016 | 4007 | 0.560 |
Why?
|
| Immunization Schedule | 2 | 2016 | 227 | 0.550 |
Why?
|
| Cost of Illness | 4 | 2014 | 1935 | 0.540 |
Why?
|
| Parents | 5 | 2020 | 3563 | 0.540 |
Why?
|
| Spouses | 2 | 2015 | 283 | 0.520 |
Why?
|
| Home Nursing | 1 | 2016 | 92 | 0.520 |
Why?
|
| Patient Preference | 4 | 2017 | 925 | 0.510 |
Why?
|
| Spouse Abuse | 4 | 2008 | 182 | 0.460 |
Why?
|
| Attitude to Health | 5 | 2015 | 2024 | 0.460 |
Why?
|
| Vaccines | 2 | 2023 | 838 | 0.410 |
Why?
|
| Models, Economic | 1 | 2016 | 714 | 0.410 |
Why?
|
| Chronic Disease | 4 | 2016 | 9311 | 0.400 |
Why?
|
| Immunization | 1 | 2016 | 1217 | 0.390 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2016 | 3194 | 0.390 |
Why?
|
| Economics, Pharmaceutical | 1 | 2012 | 87 | 0.380 |
Why?
|
| Family Health | 1 | 2016 | 1253 | 0.370 |
Why?
|
| Opioid-Related Disorders | 4 | 2017 | 2164 | 0.320 |
Why?
|
| Health | 1 | 2012 | 398 | 0.320 |
Why?
|
| Family Characteristics | 2 | 2012 | 992 | 0.310 |
Why?
|
| Sickness Impact Profile | 4 | 2019 | 299 | 0.290 |
Why?
|
| Comorbidity | 4 | 2021 | 10505 | 0.270 |
Why?
|
| Substance-Related Disorders | 4 | 2021 | 4416 | 0.270 |
Why?
|
| Vaginal Smears | 1 | 2009 | 499 | 0.270 |
Why?
|
| Quality-Adjusted Life Years | 6 | 2019 | 1722 | 0.270 |
Why?
|
| Data Collection | 4 | 2012 | 3315 | 0.270 |
Why?
|
| Decision Making | 6 | 2020 | 3918 | 0.260 |
Why?
|
| Cross-Sectional Studies | 12 | 2020 | 26049 | 0.250 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2015 | 2020 | 0.250 |
Why?
|
| Domestic Violence | 1 | 2006 | 180 | 0.240 |
Why?
|
| Qualitative Research | 2 | 2014 | 3016 | 0.230 |
Why?
|
| Adult | 37 | 2023 | 220969 | 0.220 |
Why?
|
| Air Bags | 2 | 2001 | 12 | 0.220 |
Why?
|
| Interviews as Topic | 6 | 2014 | 2697 | 0.220 |
Why?
|
| Humans | 69 | 2024 | 760617 | 0.220 |
Why?
|
| Women's Health | 2 | 2009 | 2065 | 0.210 |
Why?
|
| Attitude | 1 | 2007 | 772 | 0.200 |
Why?
|
| Algorithms | 1 | 2022 | 14018 | 0.200 |
Why?
|
| Adolescent | 16 | 2024 | 88234 | 0.190 |
Why?
|
| Psychometrics | 4 | 2024 | 3060 | 0.190 |
Why?
|
| Infant Equipment | 1 | 2001 | 23 | 0.190 |
Why?
|
| United States | 12 | 2021 | 72272 | 0.190 |
Why?
|
| Quality Assurance, Health Care | 1 | 2011 | 2164 | 0.180 |
Why?
|
| Female | 48 | 2024 | 392148 | 0.180 |
Why?
|
| Health Status Indicators | 3 | 2012 | 969 | 0.180 |
Why?
|
| Automobiles | 1 | 2001 | 111 | 0.180 |
Why?
|
| Legislation, Medical | 1 | 2021 | 98 | 0.180 |
Why?
|
| Middle Aged | 34 | 2021 | 220584 | 0.180 |
Why?
|
| Patients | 1 | 2007 | 906 | 0.180 |
Why?
|
| Young Adult | 13 | 2021 | 59179 | 0.170 |
Why?
|
| Early Detection of Cancer | 2 | 2015 | 3196 | 0.170 |
Why?
|
| Health Care Rationing | 1 | 2003 | 436 | 0.170 |
Why?
|
| Australia | 3 | 2024 | 1248 | 0.170 |
Why?
|
| Advisory Committees | 1 | 2023 | 787 | 0.160 |
Why?
|
| Healthcare Disparities | 2 | 2015 | 3351 | 0.160 |
Why?
|
| Delivery of Health Care | 3 | 2023 | 5332 | 0.150 |
Why?
|
| Linear Models | 4 | 2016 | 5866 | 0.150 |
Why?
|
| Motor Vehicles | 1 | 1999 | 282 | 0.150 |
Why?
|
| Alcohol Drinking | 2 | 2021 | 4025 | 0.150 |
Why?
|
| Focus Groups | 3 | 2015 | 1409 | 0.150 |
Why?
|
| Posture | 1 | 2001 | 956 | 0.140 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2016 | 12142 | 0.140 |
Why?
|
| Male | 34 | 2024 | 360358 | 0.140 |
Why?
|
| Dysphonia | 1 | 2019 | 144 | 0.140 |
Why?
|
| Safety | 1 | 2001 | 1149 | 0.140 |
Why?
|
| Vaccination | 3 | 2023 | 3370 | 0.130 |
Why?
|
| Ethics, Medical | 1 | 2021 | 783 | 0.130 |
Why?
|
| Accidents, Traffic | 1 | 2001 | 816 | 0.130 |
Why?
|
| Air Pollution, Indoor | 1 | 2003 | 900 | 0.130 |
Why?
|
| Child Behavior | 1 | 2001 | 848 | 0.130 |
Why?
|
| Health Surveys | 3 | 2016 | 4037 | 0.120 |
Why?
|
| HIV Infections | 3 | 2016 | 17337 | 0.120 |
Why?
|
| Risk | 1 | 2007 | 9604 | 0.120 |
Why?
|
| Diabetic Neuropathies | 1 | 2018 | 405 | 0.120 |
Why?
|
| Liver Diseases | 1 | 2003 | 1297 | 0.120 |
Why?
|
| Breast Neoplasms | 4 | 2016 | 20988 | 0.110 |
Why?
|
| Aged | 20 | 2018 | 169042 | 0.110 |
Why?
|
| Battered Women | 3 | 2008 | 35 | 0.110 |
Why?
|
| Depression | 5 | 2016 | 8132 | 0.110 |
Why?
|
| Child, Preschool | 8 | 2024 | 42188 | 0.110 |
Why?
|
| Pest Control, Biological | 1 | 2012 | 20 | 0.100 |
Why?
|
| Child | 12 | 2024 | 80079 | 0.100 |
Why?
|
| Neoplasms | 5 | 2020 | 22131 | 0.100 |
Why?
|
| Communication | 3 | 2020 | 3849 | 0.100 |
Why?
|
| Primary Health Care | 3 | 2018 | 4668 | 0.100 |
Why?
|
| Aedes | 1 | 2012 | 97 | 0.100 |
Why?
|
| Mosquito Control | 1 | 2012 | 106 | 0.100 |
Why?
|
| Barrett Esophagus | 2 | 2006 | 492 | 0.100 |
Why?
|
| Socioeconomic Factors | 6 | 2014 | 7798 | 0.100 |
Why?
|
| Mental Health | 2 | 2021 | 3251 | 0.090 |
Why?
|
| Biomedical Research | 2 | 2017 | 3426 | 0.090 |
Why?
|
| Opiate Substitution Treatment | 1 | 2015 | 444 | 0.090 |
Why?
|
| Insecticides | 1 | 2012 | 191 | 0.090 |
Why?
|
| Monitoring, Physiologic | 1 | 2018 | 1779 | 0.090 |
Why?
|
| Paranasal Sinus Diseases | 1 | 2011 | 121 | 0.090 |
Why?
|
| Value of Life | 1 | 2011 | 98 | 0.090 |
Why?
|
| Otolaryngology | 1 | 2017 | 693 | 0.090 |
Why?
|
| Age Factors | 7 | 2012 | 18381 | 0.090 |
Why?
|
| Evaluation Studies as Topic | 1 | 2012 | 1623 | 0.080 |
Why?
|
| Genetic Testing | 2 | 2021 | 3533 | 0.080 |
Why?
|
| Psoriasis | 2 | 2008 | 944 | 0.080 |
Why?
|
| Fever | 1 | 2016 | 1618 | 0.080 |
Why?
|
| Infant | 5 | 2020 | 36152 | 0.080 |
Why?
|
| Physicians, Primary Care | 1 | 2015 | 617 | 0.080 |
Why?
|
| Cerebral Palsy | 1 | 2013 | 474 | 0.070 |
Why?
|
| Hypercholesterolemia | 1 | 2015 | 1141 | 0.070 |
Why?
|
| Arthritis | 1 | 2013 | 680 | 0.070 |
Why?
|
| Comparative Effectiveness Research | 1 | 2012 | 708 | 0.070 |
Why?
|
| Mass Screening | 2 | 2015 | 5424 | 0.070 |
Why?
|
| Stress, Psychological | 3 | 2014 | 4488 | 0.070 |
Why?
|
| Canada | 1 | 2012 | 2118 | 0.070 |
Why?
|
| Regression Analysis | 2 | 2014 | 6338 | 0.070 |
Why?
|
| Aged, 80 and over | 7 | 2014 | 58894 | 0.070 |
Why?
|
| Costs and Cost Analysis | 2 | 2009 | 1663 | 0.060 |
Why?
|
| Health Care Costs | 2 | 2009 | 3238 | 0.060 |
Why?
|
| Patient Satisfaction | 3 | 2009 | 3451 | 0.060 |
Why?
|
| Europe | 1 | 2012 | 3413 | 0.060 |
Why?
|
| Professional-Patient Relations | 2 | 2008 | 724 | 0.060 |
Why?
|
| Guideline Adherence | 1 | 2015 | 2218 | 0.060 |
Why?
|
| Asthma | 1 | 2003 | 6233 | 0.060 |
Why?
|
| Severity of Illness Index | 5 | 2019 | 15828 | 0.060 |
Why?
|
| Age of Onset | 1 | 2011 | 3302 | 0.060 |
Why?
|
| Seizures | 1 | 2016 | 2954 | 0.060 |
Why?
|
| Critical Illness | 1 | 2016 | 2709 | 0.050 |
Why?
|
| Pilot Projects | 5 | 2020 | 8618 | 0.050 |
Why?
|
| Hepatitis C | 1 | 2013 | 1579 | 0.050 |
Why?
|
| Office Visits | 1 | 2006 | 593 | 0.050 |
Why?
|
| Social Perception | 1 | 2006 | 431 | 0.050 |
Why?
|
| Pediatric Assistants | 1 | 2001 | 8 | 0.050 |
Why?
|
| Primary Prevention | 1 | 2009 | 1185 | 0.050 |
Why?
|
| Factor Analysis, Statistical | 1 | 2024 | 997 | 0.050 |
Why?
|
| Self Care | 1 | 2007 | 796 | 0.050 |
Why?
|
| Endoscopy | 1 | 2011 | 1851 | 0.050 |
Why?
|
| Seat Belts | 1 | 2001 | 60 | 0.050 |
Why?
|
| Disabled Persons | 1 | 2011 | 1226 | 0.050 |
Why?
|
| Decision Support Techniques | 2 | 2008 | 1998 | 0.050 |
Why?
|
| Health Services Accessibility | 2 | 2016 | 5430 | 0.040 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 3244 | 0.040 |
Why?
|
| Boston | 3 | 2007 | 9313 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2011 | 3680 | 0.040 |
Why?
|
| Needs Assessment | 1 | 2005 | 1139 | 0.040 |
Why?
|
| Esophagus | 1 | 2005 | 1031 | 0.040 |
Why?
|
| Massachusetts | 2 | 2009 | 8833 | 0.040 |
Why?
|
| Dementia | 1 | 2013 | 2680 | 0.040 |
Why?
|
| Longitudinal Studies | 2 | 2024 | 14591 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 7389 | 0.040 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2019 | 224 | 0.040 |
Why?
|
| Logistic Models | 3 | 2001 | 13245 | 0.040 |
Why?
|
| Child Welfare | 1 | 2001 | 521 | 0.030 |
Why?
|
| Time Factors | 3 | 2020 | 39913 | 0.030 |
Why?
|
| New England | 1 | 1999 | 1051 | 0.030 |
Why?
|
| Multivariate Analysis | 2 | 2007 | 12043 | 0.030 |
Why?
|
| Automobile Driving | 1 | 2001 | 441 | 0.030 |
Why?
|
| Educational Status | 1 | 2003 | 2509 | 0.030 |
Why?
|
| Coronary Artery Disease | 1 | 2015 | 6403 | 0.030 |
Why?
|
| Reproducibility of Results | 3 | 2008 | 20074 | 0.030 |
Why?
|
| Insulin | 2 | 2007 | 6593 | 0.030 |
Why?
|
| Random Allocation | 1 | 1999 | 2392 | 0.030 |
Why?
|
| Ambulatory Care | 1 | 2006 | 2768 | 0.030 |
Why?
|
| Heroin | 1 | 2015 | 119 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2023 | 2326 | 0.030 |
Why?
|
| Markov Chains | 2 | 2008 | 965 | 0.030 |
Why?
|
| Physician's Role | 1 | 2001 | 917 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2007 | 3085 | 0.030 |
Why?
|
| Health Services, Indigenous | 1 | 2014 | 47 | 0.030 |
Why?
|
| Esophagoscopy | 2 | 2006 | 397 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 1999 | 3410 | 0.030 |
Why?
|
| Methadone | 1 | 2015 | 321 | 0.030 |
Why?
|
| Sex Factors | 1 | 2006 | 10548 | 0.020 |
Why?
|
| Family Relations | 1 | 2014 | 315 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2018 | 2700 | 0.020 |
Why?
|
| Life Style | 1 | 2003 | 3904 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 2003 | 2329 | 0.020 |
Why?
|
| Cause of Death | 1 | 2001 | 3683 | 0.020 |
Why?
|
| American Heart Association | 1 | 2015 | 1039 | 0.020 |
Why?
|
| Population Surveillance | 2 | 2014 | 2595 | 0.020 |
Why?
|
| Depressive Disorder, Major | 1 | 2007 | 4764 | 0.020 |
Why?
|
| Telemedicine | 1 | 2006 | 3050 | 0.020 |
Why?
|
| Photochemotherapy | 2 | 2006 | 823 | 0.020 |
Why?
|
| Melanoma | 1 | 2006 | 5697 | 0.020 |
Why?
|
| Xanthenes | 1 | 2007 | 71 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 17878 | 0.020 |
Why?
|
| Causality | 1 | 2014 | 1240 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2013 | 2567 | 0.020 |
Why?
|
| Pennsylvania | 1 | 2008 | 612 | 0.020 |
Why?
|
| Adaptation, Psychological | 2 | 2008 | 2629 | 0.020 |
Why?
|
| Viral Load | 1 | 2015 | 3325 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2011 | 2925 | 0.020 |
Why?
|
| Pregnancy | 1 | 2007 | 29868 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2020 | 64568 | 0.020 |
Why?
|
| Genetic Counseling | 1 | 2009 | 627 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2011 | 1467 | 0.020 |
Why?
|
| Hospitals, Urban | 1 | 2006 | 500 | 0.010 |
Why?
|
| Financing, Personal | 1 | 2006 | 308 | 0.010 |
Why?
|
| Rhinitis | 1 | 2011 | 747 | 0.010 |
Why?
|
| Risk-Taking | 1 | 2009 | 1037 | 0.010 |
Why?
|
| Anti-Retroviral Agents | 1 | 2013 | 1782 | 0.010 |
Why?
|
| Intensive Care Units | 1 | 2016 | 3742 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 2849 | 0.010 |
Why?
|
| Follow-Up Studies | 3 | 2011 | 39063 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2011 | 2241 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 2005 | 957 | 0.010 |
Why?
|
| Prospective Studies | 3 | 2013 | 54360 | 0.010 |
Why?
|
| Nitriles | 1 | 2007 | 971 | 0.010 |
Why?
|
| Sinusitis | 1 | 2011 | 991 | 0.010 |
Why?
|
| Demography | 1 | 2006 | 1643 | 0.010 |
Why?
|
| Radiotherapy | 1 | 2008 | 1497 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2005 | 20556 | 0.010 |
Why?
|
| Sexual Partners | 1 | 2006 | 800 | 0.010 |
Why?
|
| Mucous Membrane | 1 | 2005 | 659 | 0.010 |
Why?
|
| Brachytherapy | 1 | 2008 | 1223 | 0.010 |
Why?
|
| Diabetic Angiopathies | 1 | 2006 | 803 | 0.010 |
Why?
|
| Esophagectomy | 1 | 2005 | 467 | 0.010 |
Why?
|
| Deglutition Disorders | 1 | 2006 | 626 | 0.010 |
Why?
|
| Rhode Island | 1 | 2001 | 351 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2020 | 26180 | 0.010 |
Why?
|
| Patient Selection | 1 | 2011 | 4237 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2007 | 2208 | 0.010 |
Why?
|
| Analgesics, Opioid | 1 | 2015 | 3805 | 0.010 |
Why?
|
| Risk Assessment | 2 | 2011 | 23972 | 0.010 |
Why?
|
| Risk Factors | 2 | 2007 | 74115 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2007 | 4010 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2015 | 10199 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2007 | 2688 | 0.010 |
Why?
|
| Dermatology | 1 | 2006 | 918 | 0.010 |
Why?
|
| Physician-Patient Relations | 1 | 2009 | 3239 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2011 | 41457 | 0.010 |
Why?
|
| Esophageal Neoplasms | 1 | 2006 | 1653 | 0.010 |
Why?
|
| Health Behavior | 1 | 2007 | 2643 | 0.010 |
Why?
|
| Recurrence | 1 | 2006 | 8426 | 0.010 |
Why?
|
| Anxiety | 1 | 2008 | 4570 | 0.010 |
Why?
|
| Registries | 1 | 2009 | 8207 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2005 | 3567 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2007 | 11116 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2001 | 2486 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 14648 | 0.010 |
Why?
|
| Incidence | 1 | 2007 | 21337 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2007 | 9277 | 0.010 |
Why?
|
| Animals | 1 | 2012 | 168201 | 0.000 |
Why?
|
Concepts
(246)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(30)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_